Downstream Processing Market By Technology (Purification, Separation, Clarification/Concentration), By Product (Chromatography Columns and Resins, Filters, Membrane Adsorbers, Other Products), By System (Single Use System, Re Usable System), By Application (Monoclonal Antibody Production, Vaccine Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production, Other Applications), By End User (Biopharmaceutical Manufacturers, Contract Manufacturing Organizations (CMOs)): Global Opportunity Analysis and Industry Forecast, 2020-2030
Downstream processing refers to the recovery and purification of biosynthetic products, particularly pharmaceuticals, from natural sources such as animal or plant tissue or fermentation broth. It is an essential step in the manufacture of pharmaceuticals such as antibiotics, hormones (e.g., insulin and human growth hormone), antibodies (e.g., infliximab and abciximab) and vaccines; antibodies and enzymes used in diagnostics; industrial enzymes; and natural fragrance and flavor compounds. Downstream processing is usually considered a specialized field in biochemical engineering. The key factors that drive the growth of the market are increase in demand for biopharmaceuticals as downstream processing plays a key role in providing pure biopharmaceutical products. In addition, rise in R&D expenditure for biopharmaceutical products majorly drive the growth of the market. Furthermore, rise in adoption of single-use systems, low risk of product cross contamination and cost-effectiveness are the key factors anticipating the growth of market in upcoming years. In addition, single-use system in downstream processing is highly efficient and cost-effective, which attract pharmaceutical manufacturers to adopt disposable bioprocessing products drive the growth of the market in upcoming years. However, dearth and shortage of skilled bioprocess engineers is expected to restrain the market growth in upcoming years. Moreover, untapped markets such as China and India, offer profitable opportunities to expand this market. The downstream processing market is segmented on the basis of technique, product, system application, end user, and region. By technique, it is categorized into purification, separation, and clarification/concentration. Depending on product, it is classified into chromatography columns and resins, filters, membrane absorbers, and other products. By system, it is bifurcated into single use system and re-usable system. By application, it is divided into monoclonal antibody production, vaccine production, insulin production, immunoglobulin production, erythropoietin production, and other applications. By end user, it is categorized into biopharmaceutical manufacturers, and contract manufacturing organizations (CMOs). Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). North America accounted for the largest market share in the downstream processing market in 2020 and is expected to retain its dominance throughout the forecast period. This is primarily attributed to increase in R&D activities for biopharmaceuticals, considerable investments made by the market players and increase in government support are fueling the growth of the market in this region. The major companies profiled in this report include, 3M Company, Sartorius Stedim Biotech S.A, Danaher Corporation, Thermo Fisher Scientific Inc., Merck & Co., Inc., Boehringer Ingelheim, Lonza Group AG, Eppendorf AG, Finesse Solutions, Inc. and Repligen Corporation
Key Benefits For Stakeholders ?This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of theDownstream Processing Market Size analysis from 2020 to 2030 to identify the prevailing downstream processing market opportunities. ?The market research is offered along with information related to key drivers, restraints, and opportunities. ?Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network. ?In-depth analysis of the downstream processing market segmentation assists to determine the prevailing market opportunities. ?Major countries in each region are mapped according to their revenue contribution to the global market. ?Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players. ?The report includes the analysis of the regional as well as global downstream processing market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Technology ? Purification ? Separation ? Clarification/Concentration
By Product ? Chromatography Columns and Resins ? Filters ? Membrane Adsorbers ? Other Products
By System ? Single Use System ? Re Usable System
By Application ? Monoclonal Antibody Production ? Vaccine Production ? Insulin Production ? Immunoglobulin Production ? Erythropoietin Production ? Other Applications
By End User ? Biopharmaceutical Manufacturers ? Contract Manufacturing Organizations (CMOs)
By Region ? North America ? U.S. ? Canada ? Mexico ? Europe ? Germany ? France ? U.K. ? Italy ? Spain ? Rest of Europe ? Asia-Pacific ? Japan ? China ? India ? Australia ? South Korea ? Rest Of Asia Pacific ? LAMEA ? Brazil ? Saudi Arabia ? South Africa ? Rest of LAMEA ? Key Market Players ? Thermo Fisher Scientific Inc. ? Sartorius Stedim Biotech S.A ? Bio Rad Laboratories, Inc ? 3M Company ? Lonza Group AG ? Eppendorf AG ? Marathon Petroleum Corporation ? Merck KGaA. ? Religen Inc ? Agilent Technologies Inc.
Our reports have been used by over 10K customers, including:
The global fill-finish manufacturing market size is projected to grow from USD 15.2 billion by 2027 from USD 9.2 billion in 2022 at a CAGR of 10.7% from 2022 to 2027. Factors such as the rising adoption of prefilled syringes for parenteral dosage forms and increasing technological advancements are driving the market. The high costs associated...
COVID-19 has accelerated the need for a faster, more accessible clinical trial process. During the height of the pandemic, in-person follow-ups for ongoing trials were replaced with hand-held devices that essentially built an ecosystem for home health care support services that can be easily leveraged to avoid or reduce participant dropout...
170 pages •
By Transparency Market Research
• Jun 2022
Hygienic Diaphragm Valves in Biopharma Market – Scope of Report This report on the global hygienic diaphragm valves in biopharma market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031.The report...
INTRODUCTION Over the last few decades, the development landscape of small molecule drugs has been significantly impacted by various biotechnology breakthroughs. Further, with the advent of novel technologies, biologics have made a significant impact in the pharmaceutical domain, delivering ground-breaking treatment for...
The cardiac safety services market is projected to reach USD 1.0 Billion by 2027 from USD 0.6 Billion in 2022, at a CAGR of 11.2% during the forecast period. The increasing expenditure by pharmaceutical companies, alongside rising government spending is leading has driven the pace of R&D activity in this industry to develop new drugs. This...
The Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022 report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies. This report provides...
360 pages •
By Global Industry Analysts
• Oct 2022
Abstract: What’s New for 2022? Global competitiveness and key competitor percentage market shares Market presence across multiple geographies - Strong/Active/Niche/Trivial Online interactive peer-to-peer collaborative bespoke updates Access to our digital archives and MarketGlass Research...
The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022 report provides details of the latest distribution agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of distribution agreements from...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.